期刊文献+

三级综合医院多药耐药菌感染监测分析 被引量:5

Surveillance of multidrug-resistant bacteria infections in a tertiary general hospital
原文传递
导出
摘要 目的了解多药耐药菌感染在三级综合医院分布特征及规律,为有效预防控制多药耐药菌医院感染提供依据。方法采用Phonenix100全自动细菌鉴定仪进行病原菌菌种鉴定,回顾性调查2013年全年医院多药耐药菌感染患者的临床资料,应用WHONET5.4软件进行统计描述和分析。结果全年共检出目标菌3 115株,多药耐药菌为541株,占17.37%,以多药耐药鲍氏不动杆菌感染最为多见,其次为耐甲氧西林金黄色葡萄球菌;其中,男性患者明显多于女性,并且以高龄和低龄患者居多,年龄≥60岁老年患者占36.78%,而年龄≤1岁婴儿占10.17%;多药耐药菌前3位标本来源分别为呼吸道、创面分泌物和尿标本,其中呼吸道标本占56.56%;呼吸道标本和尿标本中均以多药耐药鲍氏不动杆菌最多,创面分泌物中则以耐甲氧西林金黄色葡萄球菌最多;多药耐药菌感染患者多数分布在ICU中,占全部菌株的34.38%。结论多药耐药菌感染分布较广,应高度重视多药耐药菌感染的预防控制工作,从整体上预防、控制耐药菌的产生和传播。 OBJECTIVE To understand the distribution of multidrug-resistant bacteria infections in a tertiary general hospital so as to provide guidance for effective control of nosocomial infections caused by the multidrug-resistant bacteria. METHODS The identification of pathogens was performed by using Phonenix100 automatic bacteria iden- tification system, then the clinical data of the patients with multidrug-resistant bacteria infections were retrospec- tively investigated in 2013, and the statistical analysis was performed with the use of WHONET5.4 software. RESULTS A total of 3 115 strains of targeted bacteria have been isolated in the whole year, among which there were 541 (17.37 % ) strains of multidrug-resistant bacteria; the multidrug-resistant Acinetobacter baumannii was the most common species, followed by the methicillin-resistant Staphylococcus aureus. The male patients were sig- nificantly more than the female patients% the patients aged more than 60 years otd accounted for 36.78%, while the infants aged less than one year old accounted for 10.17%. The respiratory tract specimens, wound secretions, and urine specimens ranked the top three specimens sources from which the multidrug-resistant bacteria were isola- ted, and the respiratory tract specimens accounted for 56. 56%. The majority of the multidrug-resistant A. bau- mannii strains were isolated from the respiratory tract specimens and the urine specimens. Most of the cases of multidrug-resistant bacteria infections were in the ICU, accounting for 34. 38%. CONCLUSION The multidrug-re- sistant bacteria infections are widely distributed, and it is necessary to pay high attention to the prevention and control of multidrug-resistant bacteria infections so as to prevent the transmission of the drug-resistant strains as a whole.
出处 《中华医院感染学杂志》 CAS CSCD 北大核心 2014年第10期2425-2427,共3页 Chinese Journal of Nosocomiology
基金 山东省医药卫生科技发展基金资助项目(2011HW056) 中华医院感染控制研究基金资助项目(ZHYY2013-024)
关键词 多药耐药菌 感染 分析 Multidrug-resistant bacteria Infection Analysis
  • 相关文献

参考文献6

  • 1晏群,李军,李虹玲,邬靖敏,邹明祥,刘文恩.2011年湘雅医院临床分离病原菌分布及耐药性分析[J].中国病原生物学杂志,2012,7(7):539-543. 被引量:16
  • 2Irfan S, Turton JF, Mehrsj J, et al. Molecular and epidemio- logical characterization of clinical isolates of carbapenem-re- sistant Acinetobacter baumannii from public and private secti- or intensive care units in Karachi, Pakistan[J]. J Hosp In- fect,2011,78(2) :143-148.
  • 3Chen TL, Lee YT,Kuo SC, et al. Emergence and distribution of plasmids bearing the blaOXA-51-1ike gene with an up- stream ISA-bal in carbapenem-resistant Aclnetobacter bau- mannli isolates in Taiwan[J]. Antimicrob Agents Chemoth- er,2010,54(11) :.4578-4581.
  • 4Steinmann J, Kaase M, Gatermann S,et al. Outbreak due to a Klebsiella pneumoniae strain harbouring KPC-2 and VIM-1 in a German university hospital,July 2010 to January 2011[J]. Euro Surveill, 2011,16(33) : 19944.
  • 5Peleg AY,Seifert H,Paterson DL. Acinetobacter baumannii: emergence of a successful pathogen[J]. Clin Microbiol Rev, 2008,21 : 538-582.
  • 6王珂.多重耐药菌感染的目标性监测与分析[J].中国现代药物应用,2012,6(18):13-15. 被引量:9

二级参考文献23

  • 1Clinical and I.abooratory Standards Institute (CLSI). Performance stands for antimicrobial susceptibility testing[S]. MIO0 S21, 2011.
  • 2朱德妹,汪复,胡付品,等.20lO年中国CHINET细茼耐药性盼测[J].中国感染与化疗杂志,201l,1l(5):32l-9.
  • 3Chen TL, l.ee YT, Kuo St_7, et al. Emergence and distribution ofplasmids bearing the blaOXA-51 like gene with an upstream ISA- hal in carbapenem-resistant Acinetobacter I)aumannii isolates in Taiwan[J]. Antimierob AgentsChemother, 2010, 54(11): 4578 -81.
  • 4Steinmann J, Kaase M, Gatermann S, et al. Outbreak due to a Klebsiella pzteuTttortiae strain harhouring KPC 2 and VIM I in a German university hospital, July 2010 to January 2011[J].Euro Surveill, 2011, 16(33): 19944.
  • 5Irfan S, Turton JF, Mehrsj J, et al. Molecular and epidemiologi cal characterization of clinical isolates of carlapenem resistant Acinetobacter baumannii from public and private seetior intensive care units in Karachi, Pakistan[J].]. J Hosp Infect, 2011, 78(2) : 143-8.
  • 6Marchaim D, Chopra T, Pogue JM, et al. Outbreak of colistin resl poll 201 tant, carbapenem-resistant Klebsiella pneumoniae in metro an Detroit, Michigan [J].Antimicrob Agents Chemother , 55(2): 593-9.
  • 7Suh JY, Son JS, Chung DR, et al. Nonclonal emergence of co listin resistant K&bsiella pneumoniae isolates from blood samples in South Korea[J]. Antimicrob Agents Chemother, 2010, 54 (1): 560-2.
  • 8Antoniadou A, Kontopidou F, Poulakou G, et ai. Coiistion-re- sistant isolates of Klebsiella pneurnoniae emerging in intensive care unit patients:first report of a multiclonal cluster[J]. J Anti microb Chemother, 2007, 59(4): 786-90.
  • 9Falagas ME, Bliziotis IA. Pandrug resistant Gram-negative bac teria: the dawn of the post antibiotic era[J].Int J Antimicrob Agents, 2007, 29(6): 630-6.
  • 10Robinson DA, Enright MC. Multilocus sequence typing and the e- volution of met hicillin resistant Staphylococcus aureus. Clin Mi- cmbiol infect,2004,10 ( 2 ) : 92-97.

共引文献23

同被引文献39

  • 1卫生部办公厅.关于抗菌药物临床应用管理有关问题的通知[Z].卫办医政发[2009]38号,2009.
  • 2WHO.Promoting rational use of medicines:core components,WHO Policy Perspectives on Medicines[R].September 2002,Geneva.
  • 3Zilberberg MD,Chen J,Mody SH,et al.Imipenem resistance of Pseudomonasin pneumonia:a systematic literature review[J].BMC Pulm Med,2010,26(10):45.
  • 4肖永红李兰娟.2010年度卫生部全国细菌耐药监测(Mohnarin)报告[M].天津:天津科学出版社,2012:70.
  • 5Yagupsky P.Selection of antibiotic-resitant pathogens in the commanityf[J].Pediatr Infect Dis J,2006,48(8):161-178.
  • 6WHO&Management Science for Health,Drug&Therapeutics Committee.A Practical Guide[R].Geneva,2003.
  • 7Dellit TH,Owens RC,Mc Gowan JE Jr,et al.Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America Guidelines for Developing an nstitutional Program to Enhance ntimicrobial Stewardship[J].Clin Infect Dis,2007,1(2):159-177.
  • 8Zilberberg MD,Chen J,Mody SH,et al.Imipenem resistance of Pseudomonas in pneumonia:a systematic literature review[J].BMC Pulm Med,2010,26(10):45.
  • 9Yagupsky P.Selection of antibiotic-resitant pathogens in the commanityf[J].Pediatr Infect Dis J,2006,48(8):161-178.
  • 10Dellit TH,Owens RC,McGowan JE Jr,et al.Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America Guidelines for Developing an institutional Program to Enhance Antimicrobial Stewardship[J].Clin Infect Dis,2007(2):159-177.

引证文献5

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部